Hutchison China MediTech Limited logo
Hutchison China MediTech Limited HCM
$ 13.82 -3.56%

Annual report 2024
added 02-28-2026

report update icon

Hutchison China MediTech Limited Financial Ratios 2011-2026 | HCM

Annual Financial Ratios Hutchison China MediTech Limited

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

339.8 127.4 -31.2 -111.0 -159.5 -146.4 -231.7 -776.9 -19.6 - - - - -

P/S

- - - 60.7 88.0 75.8 80.9 86.1 3.9 - - - - -

EPS

0.0 0.1 -0.4 -0.2 -0.2 -0.2 -0.1 -0.0 0.2 -0.6 -0.6 - - -

EV (Enterprise Value)

- - - 21.9 B 20 B 15.6 B 17.4 B 20.8 B 902 M 95.5 M 60.1 M 80.8 M 126 M 117 M

EBITDA per Share

-0.04 0.03 -0.47 -0.41 -0.27 -0.21 -0.13 -0.08 -0.782 - - - - -

EV/EBITDA

-66.6 -110.3 -115.5 -16.3 -43.5 -17.4 - - - - -

PEG

-6.95 12.68 -0.71 -4.84 1.32 1.19 -2.37 -13.59 0.0 - - - - -

P/B

16.6 17.3 17.7 20.8 38.7 49.6 42.0 181.8 4.1 - - - - -

P/CF

25798.2 58.6 -41.9 -105.8 -323.2 -191.9 -527.6 -2322.6 -748.8 - - - - -

ROE %

4.96 13.80 -56.66 -18.72 -24.23 -33.88 -18.15 -5.53 -21.08 - - - - -

ROA %

2.96 7.87 -35.05 -14.18 -17.36 -22.79 -14.06 -12.81 -12.56 - - - - -

ROCE %

- - - -31.58 -34.76 -42.35 -21.06 -11.01 -18.88 - - - - -

Current Ratio

2.5 2.4 2.6 4.1 3.5 3.1 4.4 2.2 1.8 - - - - -

DSO

- - - 23.9 70.5 72.7 67.0 59.9 68.9 - - - - -

DIO

- - - 110.6 103.3 112.5 124.4 180.8 - - - - - -

DPO

- - - 145.0 159.6 195.7 258.2 402.1 - - - - - -

Operating Cycle

- - - 134.5 173.8 185.2 191.4 240.7 - - - - - -

Cash Conversion Cycle

- - - -10.5 14.2 -10.5 -66.7 -161.4 - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Hutchison China MediTech Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

- - - - - - - - - - - - - - - -0.03 - - - -0.02 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

- - - - - - - - - - - - - - - -0.05 - - - -0.04 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

- - - - - - - - - - - -5.29 -10.58 -10.58 -5.29 -7.74 -4.90 -4.90 -2.45 -2.45 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

- - - - - - - - - - - -3.69 -7.37 -7.37 -3.69 -3.69 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROCE %

- - - - - - - - - - - -9.59 -19.19 -19.19 -9.59 -14.82 -10.46 -10.46 -5.23 -5.23 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

- - - - 4.1 - 4.9 - 3.5 - 3.3 - 3.1 3.9 4.0 3.9 4.4 - 4.8 - 5.3 - 2.6 - 2.5 - - - 1.8 - - - - - - - - - - - - - - - - - - -

DSO

- - - - - - - - - - - - - - - 72.1 - - - 33.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - 120.9 - - - 68.5 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - 227.8 - - - 141.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

- - - - - - - - - - - - - - - 193.0 - - - 102.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

- - - - - - - - - - - - - - - -34.8 - - - -39.6 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Multiples are an important financial analysis tool for the company Hutchison China MediTech Limited, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Biotechnology industry

Issuer Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M germanyGermany
Xeris Pharmaceuticals Xeris Pharmaceuticals
XERS
$ 6.03 -1.55 % $ 885 M usaUSA
I-Mab I-Mab
IMAB
- - $ 866 M chinaChina
UroGen Pharma Ltd. UroGen Pharma Ltd.
URGN
$ 19.2 -11.52 % $ 554 M israelIsrael
uniQure N.V. uniQure N.V.
QURE
$ 10.89 -30.36 % $ 530 M niderlandNiderland
GT Biopharma GT Biopharma
GTBP
$ 0.47 -2.41 % $ 892 K usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B usaUSA
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M franceFrance
AbCellera Biologics AbCellera Biologics
ABCL
$ 3.74 3.6 % $ 1.12 B canadaCanada
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M britainBritain
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - russiaRussia
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
- - $ 2.17 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M canadaCanada
CureVac N.V. CureVac N.V.
CVAC
- - $ 867 M germanyGermany
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
- 1.93 % $ 17.4 M usaUSA
Agenus Agenus
AGEN
$ 3.36 0.86 % $ 1.2 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
- - $ 7.46 M israelIsrael
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B usaUSA
Agios Pharmaceuticals Agios Pharmaceuticals
AGIO
$ 29.16 -3.54 % $ 1.69 B usaUSA
Advaxis Advaxis
ADXS
- -9.65 % $ 45.9 M usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M usaUSA
Завод ДИОД Завод ДИОД
DIOD
- - - russiaRussia
Фармсинтез Фармсинтез
LIFE
- - - russiaRussia
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M usaUSA
Alector Alector
ALEC
$ 2.19 -9.77 % $ 226 M usaUSA
Entera Bio Ltd. Entera Bio Ltd.
ENTX
$ 1.38 -0.72 % $ 63.3 M israelIsrael
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
- 3.16 % $ 1.9 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
- 10.36 % $ 9.8 M usaUSA
Altimmune Altimmune
ALT
$ 4.21 -2.32 % $ 299 M usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
- -13.85 % $ 16.1 M usaUSA
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M usaUSA
Evogene Ltd. Evogene Ltd.
EVGN
$ 0.84 -4.24 % $ 27.9 M israelIsrael
Viela Bio, Inc. Viela Bio, Inc.
VIE
- - $ 2.91 B usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
$ 13.98 1.27 % $ 5.7 B irlandaIrlanda
AbbVie AbbVie
ABBV
$ 233.57 0.64 % $ 413 B usaUSA
Blueprint Medicines Corporation Blueprint Medicines Corporation
BPMC
- - $ 8.14 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
$ 0.8 -11.6 % $ 38.5 M usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
$ 0.83 5.37 % $ 4.53 M chinaChina
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
$ 20.67 -1.38 % $ 2.61 B usaUSA